Nifty
Sensex
:
:
14310.80
47883.38
-524.05 (-3.53%)
-1707.94 (-3.44%)

Chemicals

Rating :
62/99

BSE: 530019 | NSE: JUBLPHARMA

734.70
12-Apr-2021
  • Open
  • High
  • Low
  • Previous Close
  •  751.00
  •  793.05
  •  706.70
  •  735.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  671464
  •  5110.06
  •  1046.95
  •  325.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 11,621.15
  • 13.17
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 14,849.50
  • 0.69%
  • 1.87

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.68%
  • 3.99%
  • 15.92%
  • FII
  • DII
  • Others
  • 25.73%
  • 0.57%
  • 3.11%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.26
  • 9.75
  • 6.79

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.17
  • 9.32
  • 5.10

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.61
  • 18.05
  • 11.80

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.23
  • 15.55
  • 14.45

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.96
  • 2.43
  • 2.09

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.45
  • 8.87
  • 7.73

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Net Sales
1,771.34
1,517.98
16.69%
2,374.89
2,265.93
4.81%
1,892.92
2,181.86
-13.24%
2,391.41
2,385.58
0.24%
Expenses
1,278.58
1,107.56
15.44%
1,888.71
1,797.48
5.08%
1,590.70
1,747.26
-8.96%
1,854.80
2,027.61
-8.52%
EBITDA
492.76
410.42
20.06%
486.18
468.45
3.78%
302.22
434.60
-30.46%
536.61
357.97
49.90%
EBIDTM
27.82%
27.04%
20.47%
20.67%
15.97%
19.92%
14.01%
14.01%
Other Income
3.59
3.22
11.49%
7.28
12.26
-40.62%
8.13
9.70
-16.19%
19.44
-6.58
-
Interest
46.37
48.83
-5.04%
63.95
71.64
-10.73%
75.95
72.58
4.64%
71.16
61.59
15.54%
Depreciation
95.94
83.54
14.84%
115.84
116.84
-0.86%
112.30
102.69
9.36%
128.94
95.02
35.70%
PBT
343.15
248.33
38.18%
313.67
292.23
7.34%
122.10
269.03
-54.61%
355.95
-39.98
-
Tax
121.16
90.18
34.35%
89.55
42.84
109.03%
34.09
84.05
-59.44%
95.46
60.67
57.34%
PAT
221.99
158.15
40.37%
224.12
249.39
-10.13%
88.01
184.98
-52.42%
260.49
-100.65
-
PATM
12.53%
10.42%
9.44%
11.01%
4.65%
8.48%
7.11%
7.11%
EPS
19.46
12.77
52.39%
14.06
15.66
-10.22%
5.52
11.61
-52.45%
28.29
28.29
0.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
8,430.56
9,154.41
9,110.82
7,517.84
5,861.43
5,749.13
5,826.25
5,803.36
5,165.95
4,303.13
3,445.62
Net Sales Growth
0.95%
0.48%
21.19%
28.26%
1.95%
-1.32%
0.39%
12.34%
20.05%
24.89%
 
Cost Of Goods Sold
6,572.78
3,140.58
3,521.84
2,862.51
2,002.74
2,116.20
2,663.02
2,438.46
2,062.85
1,618.87
1,339.68
Gross Profit
1,857.78
6,013.84
5,588.98
4,655.33
3,858.69
3,632.94
3,163.23
3,364.90
3,103.10
2,684.26
2,105.95
GP Margin
22.04%
65.69%
61.34%
61.92%
65.83%
63.19%
54.29%
57.98%
60.07%
62.38%
61.12%
Total Expenditure
6,612.79
7,207.34
7,371.81
5,999.45
4,516.14
4,502.19
5,124.71
4,782.37
4,097.81
3,412.94
2,880.76
Power & Fuel Cost
-
473.80
466.38
424.91
333.66
366.71
393.04
389.74
356.73
286.89
224.04
% Of Sales
-
5.18%
5.12%
5.65%
5.69%
6.38%
6.75%
6.72%
6.91%
6.67%
6.50%
Employee Cost
-
2,127.68
1,925.96
1,555.88
1,230.93
1,125.09
1,090.28
1,105.17
962.58
836.36
718.54
% Of Sales
-
23.24%
21.14%
20.70%
21.00%
19.57%
18.71%
19.04%
18.63%
19.44%
20.85%
Manufacturing Exp.
-
602.62
552.26
485.98
428.84
436.46
432.40
405.14
360.48
329.75
284.66
% Of Sales
-
6.58%
6.06%
6.46%
7.32%
7.59%
7.42%
6.98%
6.98%
7.66%
8.26%
General & Admin Exp.
-
488.39
540.75
354.56
280.98
256.23
302.28
264.23
208.35
200.72
195.72
% Of Sales
-
5.34%
5.94%
4.72%
4.79%
4.46%
5.19%
4.55%
4.03%
4.66%
5.68%
Selling & Distn. Exp.
-
292.70
267.70
247.85
185.79
135.54
203.98
160.04
123.28
111.85
90.92
% Of Sales
-
3.20%
2.94%
3.30%
3.17%
2.36%
3.50%
2.76%
2.39%
2.60%
2.64%
Miscellaneous Exp.
-
81.58
96.92
67.76
53.20
65.96
39.72
19.59
23.53
28.50
90.92
% Of Sales
-
0.89%
1.06%
0.90%
0.91%
1.15%
0.68%
0.34%
0.46%
0.66%
0.79%
EBITDA
1,817.77
1,947.07
1,739.01
1,518.39
1,345.29
1,246.94
701.54
1,020.99
1,068.14
890.19
564.86
EBITDA Margin
21.56%
21.27%
19.09%
20.20%
22.95%
21.69%
12.04%
17.59%
20.68%
20.69%
16.39%
Other Income
38.44
47.43
35.74
40.03
24.86
13.37
42.45
19.06
29.87
31.48
17.24
Interest
257.43
287.41
219.81
284.28
341.11
371.35
367.61
337.11
310.93
238.23
119.99
Depreciation
453.02
461.93
370.90
415.05
291.40
346.74
287.95
281.17
253.79
220.65
180.10
PBT
1,134.87
1,245.17
1,184.04
859.08
737.64
542.22
88.43
421.78
533.29
462.79
282.02
Tax
340.26
312.29
326.80
224.66
163.02
155.40
80.48
69.64
152.36
68.41
13.37
Tax Rate
29.98%
25.80%
36.16%
26.15%
22.10%
28.66%
199.55%
33.60%
44.66%
59.95%
5.56%
PAT
794.61
898.24
574.46
642.81
575.66
391.83
-57.76
109.04
152.73
14.56
229.72
PAT before Minority Interest
794.62
898.24
577.01
634.42
574.63
386.82
-40.16
137.64
188.78
45.69
227.23
Minority Interest
0.01
0.00
-2.55
8.39
1.03
5.01
-17.60
-28.60
-36.05
-31.13
2.49
PAT Margin
9.43%
9.81%
6.31%
8.55%
9.82%
6.82%
-0.99%
1.88%
2.96%
0.34%
6.67%
PAT Growth
61.55%
56.36%
-10.63%
11.66%
46.92%
-
-
-28.61%
948.97%
-93.66%
 
EPS
49.88
56.39
36.06
40.35
36.14
24.60
-3.63
6.84
9.59
0.91
14.42

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
5,603.88
4,808.92
4,086.53
3,436.04
2,966.26
2,453.52
2,626.51
2,476.12
2,257.03
2,172.27
Share Capital
15.93
15.93
15.58
15.57
15.54
15.93
15.45
15.93
15.93
15.93
Total Reserves
5,587.95
4,792.94
4,070.78
3,419.98
2,950.72
2,437.59
2,611.07
2,460.19
2,241.10
2,156.34
Non-Current Liabilities
4,087.52
4,420.21
3,417.47
3,826.06
3,347.13
4,036.15
2,184.95
3,004.85
3,224.12
3,048.25
Secured Loans
728.92
811.65
729.88
1,581.96
2,620.41
3,316.29
1,716.67
1,708.74
2,839.47
2,435.91
Unsecured Loans
3,010.76
3,431.24
2,317.93
1,923.07
392.79
375.00
0.22
760.06
0.45
400.61
Long Term Provisions
150.75
114.35
107.08
80.69
70.31
67.04
219.53
237.96
169.70
39.87
Current Liabilities
2,619.01
2,089.73
2,004.69
1,684.04
2,464.44
2,129.16
3,894.41
2,778.35
2,212.79
2,269.67
Trade Payables
1,090.27
1,020.13
1,136.16
749.49
612.12
721.19
718.14
647.13
836.98
517.43
Other Current Liabilities
674.21
473.57
505.87
572.70
951.43
793.31
1,731.20
898.00
499.55
465.94
Short Term Borrowings
649.89
499.71
244.85
255.60
748.97
517.17
1,187.83
1,131.39
767.07
883.03
Short Term Provisions
204.64
96.31
117.81
106.24
151.93
97.49
257.25
101.84
109.18
403.28
Total Liabilities
12,310.41
11,318.96
9,457.17
8,898.75
8,739.70
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00
Net Block
6,339.97
5,648.38
5,400.55
5,106.73
5,104.42
4,911.33
5,098.78
4,967.46
4,460.18
3,991.05
Gross Block
7,982.83
6,905.50
6,288.86
5,672.38
5,390.82
7,362.10
7,330.63
6,870.15
6,084.09
5,163.28
Accumulated Depreciation
1,642.85
1,257.12
888.31
565.66
286.40
2,450.76
2,231.85
1,902.69
1,623.92
1,172.22
Non Current Assets
7,272.06
6,734.16
6,267.41
5,950.63
5,864.37
5,904.29
5,935.78
5,809.80
5,465.57
4,940.25
Capital Work in Progress
768.39
901.43
670.97
683.78
611.32
596.60
472.39
436.89
685.55
666.71
Non Current Investment
69.36
115.11
123.52
102.71
85.43
39.50
33.99
25.61
19.20
32.75
Long Term Loans & Adv.
86.81
68.59
71.79
56.32
62.67
327.17
328.42
379.47
299.86
249.18
Other Non Current Assets
7.53
0.66
0.58
1.08
0.53
29.68
2.21
0.37
0.79
0.55
Current Assets
5,038.35
4,584.80
3,189.76
2,948.12
2,875.32
2,714.54
2,928.03
2,561.06
2,297.32
2,591.75
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,845.38
1,417.39
1,391.39
1,220.40
1,203.10
1,235.33
1,341.42
1,116.18
1,020.22
691.28
Sundry Debtors
1,293.22
1,271.55
1,130.76
1,005.30
950.50
819.27
805.87
708.54
652.69
520.45
Cash & Bank
1,399.87
1,370.41
248.79
459.63
344.58
394.34
479.53
356.05
266.82
1,045.14
Other Current Assets
499.88
485.64
373.06
225.73
377.13
265.59
301.21
380.29
357.59
334.88
Short Term Loans & Adv.
41.33
39.80
45.75
37.06
133.06
144.56
136.04
182.01
256.70
217.50
Net Current Assets
2,419.34
2,495.07
1,185.06
1,264.08
410.88
585.38
-966.38
-217.29
84.53
322.08
Total Assets
12,310.41
11,318.96
9,457.17
8,898.75
8,739.69
8,618.83
8,863.81
8,370.86
7,762.89
7,532.00

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
1,542.94
1,121.51
1,303.20
1,268.49
1,098.89
783.26
772.27
969.90
707.17
389.75
PBT
1,210.53
903.81
859.08
737.64
542.22
40.32
207.28
341.14
114.11
240.59
Adjustment
760.74
861.53
687.81
637.90
737.89
725.84
756.60
752.36
795.44
318.42
Changes in Working Capital
-179.67
-300.53
14.15
36.88
-133.16
96.40
-110.70
-4.04
-136.91
-84.14
Cash after chg. in Working capital
1,791.60
1,464.82
1,561.04
1,412.42
1,146.96
862.57
853.18
1,089.46
772.64
474.88
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-248.66
-343.31
-257.84
-143.94
-48.07
-79.31
-80.91
-119.56
-65.47
-85.14
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-327.00
-1,011.84
-617.70
-450.39
-312.53
-343.33
-174.42
-499.72
-594.31
-352.15
Net Fixed Assets
-241.66
-305.67
-147.58
-115.33
785.60
1,162.43
-166.96
-286.05
-434.15
-275.33
Net Investments
-0.14
-57.59
3.34
-0.39
57.01
239.81
-27.56
-18.79
-95.66
5.14
Others
-85.20
-648.58
-473.46
-334.67
-1,155.14
-1,745.57
20.10
-194.88
-64.50
-81.96
Cash from Financing Activity
-1,050.37
657.43
-901.13
-685.87
-842.75
-502.69
-414.41
-449.76
-888.82
608.21
Net Cash Inflow / Outflow
165.56
767.10
-215.63
132.22
-56.38
-62.76
183.44
20.41
-775.95
645.81
Opening Cash & Equivalents
1,005.40
244.18
456.44
339.27
391.64
473.49
279.65
263.08
1,041.15
498.27
Closing Cash & Equivalent
1,230.81
1,005.40
244.18
456.44
339.27
391.63
473.49
279.65
263.08
1,041.15

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
351.83
301.93
262.33
220.61
190.90
154.04
170.07
155.46
141.70
136.38
ROA
7.60%
5.55%
6.91%
6.52%
4.46%
-0.46%
1.60%
2.34%
0.60%
3.17%
ROE
17.25%
12.97%
16.87%
17.95%
14.27%
-1.58%
5.39%
7.98%
2.06%
10.42%
ROCE
15.07%
13.06%
15.21%
14.44%
12.42%
5.72%
7.92%
10.19%
5.79%
6.29%
Fixed Asset Turnover
1.23
1.38
1.26
1.09
0.92
0.81
0.84
0.82
0.78
0.70
Receivable days
51.13
48.12
51.58
59.43
54.81
49.56
46.53
47.00
48.71
53.83
Inventory Days
65.05
56.26
63.07
73.64
75.51
78.58
75.51
73.76
71.07
71.61
Payable days
53.01
55.42
56.86
54.84
53.44
52.17
51.42
45.33
38.70
50.95
Cash Conversion Cycle
63.17
48.96
57.79
78.23
76.88
75.98
70.61
75.42
81.08
74.50
Total Debt/Equity
0.83
1.01
0.85
1.18
1.51
1.95
1.67
1.71
1.69
1.81
Interest Cover
5.21
5.11
4.02
3.16
2.46
1.11
1.61
2.10
1.48
3.01

News Update:


  • Jubilant Life Sciences raises Rs 95 crore through NCDs
    14th Jan 2021, 15:27 PM

    The company has allotted 950 NCDs of Rs 10,00,000 each on Private Placement basis

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.